Antiarrhythmic drug treatment: need for continuous vigilance.

AUTOR(ES)

Wellens, H J

RESUMO

Any physician treating cardiac arrhythmias should be aware of a possible worsening of the arrhythmia (so-called arrhythmogenesis) after the start of antiarrhythmic drug treatment. To facilitate the recognition of that complication the type and possible mechanisms of arrhythmogenesis are reviewed. Recognition also requires an understanding of (a) the time of appearance of arrhythmogenic effects after different drugs, (b) the value of non-invasive and invasive tests, and (c) the profile of the patient most likely to develop this problem. Guidelines are given to reduce the incidence of the arrhythmogenic effects of antiarrhythmic drugs and a plea is made that the physician should be always on the alert for this complication.

Documentos Relacionados

• Drug development for cryptococcosis treatment: what can patents tell us?
• Dissatisfaction with dentofacial appearance and the normative need for orthodontic treatment: determinant factors
• Antituberculosis Treatment: Increasing Evidence for Drug Effects on Innate Cellular Immunity
• Monitoring drug treatment: Criteria used for screening tests should apply to monitoring
• Social skills training for drug users under treatment: a pilot study with follow-up